Estudio de sensibilidad antifúngica para posaconazol y caspofungina en levaduras responsables de infección fúngica invasiva (2002-2003). Evaluación del sistema E-test

Fernández, Ana; Velasco, David; Lueiro, Francisco; Bou, Germán.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 26(2): 82-84, feb. 2008. tab
Artículo en Es | IBECS (España) | ID: ibc-64127

Documentos relacionados

  1. Can we predict the influence of inflammation on voriconazole exposure? An overview.
  2. Tissue penetration of antifungal agents.
  3. Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide.
  4. Antifungal Drugs TDM: Trends and Update.
  5. Posaconazole salvage therapy: The Posifi study.
  6. Liposomal amphotericin B-the past.
  7. Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
  8. New Perspectives on Antimicrobial Agents: Isavuconazole.
  9. Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.
  10. Characterization of Isavuconazole serum concentrations after enteral feeding tube administration in a hospitalized cohort: A case series.